Scientific advances offer the possibility of curing debilitating diseases, but may also widen the income gap in the process. Experts discuss the accessibility of new cures and how to ensure they do not increase the gap between rich and poor patients.
It’s a sad state of affairs when legislation is required to prevent people from harming their children.
While the US government is right to sanction and otherwise pressure the Maduro regime, it has a duty (and a self-interest) to further assist those leaving Venezuela and the nations receiving them.
It happens all the time in zombie fiction: The heroes kill the zombies even when the zombies aren’t an immediate threat. So is it okay to preemptively kill a zombie?
Robert Mugabe may no longer hold power, but cholera, inflation, and corruption still reign in Zimbabwe.
DDT is still useful for poor nations suffering from insect-borne diseases.
Ted Harada did something that no one else in recorded medical history ever did: he beat ALS.
Resident Fellow Dr. Scott Gottlieb discusses the Zika virus outbreak in southern Florida, including methods to contain the disease, the political funding battle that has ensued, and steps pregnant women should take if they are in a Zika zone.
If we desire poor countries to receive new treatments, shareholders of innovative companies should not be asked to foot the entire bill of our altruistic desires.
Rather than complain about drug prices, governments should help developing countries reform their drug approval regulations and strengthen distribution channels so proven drugs get to patients quickly and safely.